Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

There is a need for the development of novel non-steroidal topical drugs for the treatment of psoriasis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Eur Acad Dermatol Venereol

Title: Journal of the European Academy of Dermatology and Venereology : JEADV

Publisher: Wiley

ISSN (Electronic): 1468-3083

ISSN (Print): 0926-9959

Publication date (Electronic): Dec 2012

Volume: 26

Issue: 12

Affiliations

[1 ] Innovaderm Research Inc., Montreal, QC, Canada. rbissonnette@innovaderm.ca

Article

DOI: 10.1111/j.1468-3083.2011.04332.x

PubMed ID: 22077962

SO-VID: 68ab5946-f915-44b2-bf0c-13e510108c56

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by